1. Home
  2. VET vs NEO Comparison

VET vs NEO Comparison

Compare VET & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VET
  • NEO
  • Stock Information
  • Founded
  • VET 1994
  • NEO 2001
  • Country
  • VET Canada
  • NEO United States
  • Employees
  • VET N/A
  • NEO N/A
  • Industry
  • VET Oil & Gas Production
  • NEO Precision Instruments
  • Sector
  • VET Energy
  • NEO Health Care
  • Exchange
  • VET Nasdaq
  • NEO Nasdaq
  • Market Cap
  • VET 1.2B
  • NEO 1.2B
  • IPO Year
  • VET N/A
  • NEO 1999
  • Fundamental
  • Price
  • VET $9.06
  • NEO $10.40
  • Analyst Decision
  • VET
  • NEO Buy
  • Analyst Count
  • VET 0
  • NEO 10
  • Target Price
  • VET N/A
  • NEO $12.56
  • AVG Volume (30 Days)
  • VET 1.2M
  • NEO 4.1M
  • Earning Date
  • VET 11-05-2025
  • NEO 10-28-2025
  • Dividend Yield
  • VET 4.00%
  • NEO N/A
  • EPS Growth
  • VET N/A
  • NEO N/A
  • EPS
  • VET N/A
  • NEO N/A
  • Revenue
  • VET $1,445,514,003.00
  • NEO $709,162,000.00
  • Revenue This Year
  • VET $14.28
  • NEO $10.74
  • Revenue Next Year
  • VET $0.53
  • NEO $9.85
  • P/E Ratio
  • VET N/A
  • NEO N/A
  • Revenue Growth
  • VET 30.48
  • NEO 10.10
  • 52 Week Low
  • VET $5.14
  • NEO $4.72
  • 52 Week High
  • VET $10.85
  • NEO $19.12
  • Technical
  • Relative Strength Index (RSI)
  • VET 73.37
  • NEO 60.42
  • Support Level
  • VET $7.22
  • NEO $9.78
  • Resistance Level
  • VET $7.57
  • NEO $10.54
  • Average True Range (ATR)
  • VET 0.28
  • NEO 0.57
  • MACD
  • VET 0.18
  • NEO -0.05
  • Stochastic Oscillator
  • VET 94.66
  • NEO 52.99

About VET Vermilion Energy Inc. Common (Canada)

Vermilion Energy Inc is an international oil and gas-producing company. The company engages in full-cycle exploration and production programs that focus on the acquisition, exploration, development, and optimization of producing properties in North America, Europe, and Australia. The majority of Vermilion's revenue is derived from the production and sale of petroleum and natural gas. In each market, the company relies on a host of drilling and well-completion techniques to keep production at attractive levels. Geographically, the company derives majority of its revenue from Canada.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: